Year archive

ATOMO DIAGNOSTICS LIMITED — 2024 filings

All 35 regulatory filings released by ATOMO DIAGNOSTICS LIMITED (AT1) in 2024, sourced directly from the official regulator.

35 Filings

2024 Period

2024 filings (35)

Filing	Released	Lang
Results of 2024 Annual General Meeting Update 1 pag Declaration of Voting Results & Voting Rights Announcements	2024-11-18	English
Proposed issue of securities - AT1 5 pages 17.2KB Capital/Financing Update	2024-11-17	English
Chair's Address to Shareholders 4 pages 316.4KB AGM Information	2024-11-14	English
2024 Annual General Meeting - MD & CEO Address 16 pages 1.9MB AGM Information	2024-11-14	English
Results of 2024 Annual General Meeting 2 pages 323.5KB Declaration of Voting Results & Voting Rights Announcements	2024-11-14	English
Withdrawal of Resolutions at 2024 Annual General Meeting 1 AGM Information	2024-11-13	English
Atomo secures Australian order for supply of HIV Self-Tests 2 pages 101.4KB Capital/Financing Update	2024-11-12	English
Annual General Meeting Webinar 1 page 190.7KB AGM Information	2024-11-04	English
Quarterly Activities Report and Appendix 4C 10 pages 1.0MB Interim / Quarterly Report	2024-10-28	English
Atomo Investor Webinar Presentation 1 page 212.7KB Earnings Release	2024-10-23	English
Atomo Secures $2.44m Grant to Develop Syphilis Test 3 pages 299.9KB Capital/Financing Update	2024-10-22	English
2024 Notice of Annual General Meeting 18 pages 1.7MB AGM Information	2024-10-14	English
2024 Appendix 4E and Annual Report 58 pages 2.7MB Annual Report	2024-08-28	English
FY24 Results Presentation 29 pages 20.8MB Regulatory Filings	2024-08-28	English
2024 Appendix 4G and Corporate Governance Statement 29 pages 3.2MB Regulatory Filings	2024-08-28	English
Atomo Investor Webinar Presentation 1 page 188.2KB Report Publication Announcement	2024-08-28	English
Quarterly Activities Report and Appendix 4C 10 pages 1.1MB Interim / Quarterly Report	2024-07-24	English
Atomo Investor Webinar Presentation 1 page 95.6KB Investor Presentation	2024-07-21	English
Notification of cessation of securities - AT1 5 pages 17.2KB Regulatory Filings	2024-07-08	English
Change of Director's Interest Notice - John Kelly 3 pages 359.9KB Director's Dealing	2024-07-08	English
Government funded procurement of Atomo HIV tests commencing 2 pages 295.3KB Capital/Financing Update	2024-06-11	English
Change of Company Secretary 1 page 128.4KB Board/Management Information	2024-06-10	English
Significant funding to HIV Self-Testing in Federal Budget 2 pages 268.6KB Regulatory Filings	2024-05-15	English
Notification of cessation of securities - AT1 4 pages 15.4KB Regulatory Filings	2024-04-29	English
Quarterly Activities Report and Appendix 4C 10 pages 984.6KB Interim / Quarterly Report	2024-04-28	English
Atomo Investor Webinar Presentation 1 page 144.6KB Investor Presentation	2024-04-23	English
AT1 secures significant order for HIV self-tests 1 Capital/Financing Update	2024-04-14	English
AT1 secures significant order for HIV self tests for LMIC 1 Capital/Financing Update	2024-03-05	English
Change of Company Secretary 1 page 171.3KB Board/Management Information	2024-03-03	English
Appendix 4D and Half Year Report ended 31 Dec 2023 24 pages 890.8KB Interim / Quarterly Report	2024-02-25	English
H1 FY24 Results Presentation 15 pages 2.0MB Regulatory Filings	2024-02-25	English
Investor Webinar Presentation 1 page 160.4KB Report Publication Announcement	2024-02-20	English
Appendix 4C - 31 December 2023 5 pages 850.0KB Interim / Quarterly Report	2024-01-28	English
Quarterly Activity Report - 31 December 2023 6 pages 651.5KB Interim / Quarterly Report	2024-01-28	English
Investor Webinar Presentation 1 page 145.1KB Regulatory Filings	2024-01-23	English